What Should You Know About mCRPC Prostate Cancer?

It is often called mCRPC. The name describes both where the cancer is behaving in the body and how it is responding to hormone-lowering treatment; it does not describe a single, fixed treatment plan.

Metastatic means cancer cells have moved beyond the prostate to other parts of the body. Castration-resistant means the cancer has continued to grow or has progressed even while testosterone is kept at a very low level with medicines or surgery. Hormone-lowering treatment may still be continued while other treatments are added.

Your cancer team uses symptoms, examinations, blood tests, scans, previous treatments, and the sites involved to build a plan. Symptoms such as pain, tiredness, appetite changes, or urinary changes deserve specific attention because treating symptoms is an important part of care.

Keep regular oncology appointments and bring an updated list of medicines, supplements, symptoms, and any new limitations in daily activities. Tell the team about pain location, when it occurs, and whether it affects sleep, walking, or self-care. This helps them judge both cancer control and comfort.

Depending on your situation, treatment may include medicines that act on cancer cells, targeted radioisotope therapy, radiotherapy for a troublesome area, or bone-strengthening therapy when bone health needs support. The expected benefit, possible side effects, and how each option fits with earlier treatment should be discussed together.

Contact your oncology team promptly for new or rapidly worsening bone or back pain, weakness or numbness in the legs, loss of bladder or bowel control, fever, or a sudden decline in how you feel. These symptoms need timely assessment because they can require urgent treatment.

Seek urgent help if you cannot pass urine, have severe uncontrolled pain, or develop new confusion, severe shortness of breath, or chest pain. Use the emergency plan provided by your treatment centre when one is available.

Ask where the cancer is currently seen, what shows that it is castration-resistant, and what the main goal of the next treatment is. You can also ask which symptoms should prompt a same-day call, how side effects will be monitored, and whether a supportive-care specialist could help with pain, energy, mood, or practical needs.

If bone involvement is a concern, ask how your team will protect bone health and whether dental care or other checks are needed before treatment. A written list of questions can make it easier to leave the visit with a clear plan.